Verastem Oncology Sees Strategic Realignment To Reduce Its Operating Expenses By About 40%...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Feb 28, 2020 at 11:02 AM.

  1. #1 cafead, Feb 28, 2020 at 11:02 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Verastem Oncology announces strategic realignment to reduce its operating expenses, including reduction of the saleforce and non-core clinical research.

    article source
     
    Quote

Reply to Thread